FdaApplication

NDA 219097

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSHORLA ONCOLOGY
application_typeNDA
approval_date2024-11-22

Products (1)

ProductActive ingredientStrengthDosage form
IMKELDIIMATINIB MESYLATEEQ 80MG BASE/MLSOLUTION;ORAL

1 product